Literature DB >> 7768599

Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23.

H Gazzano-Santoro1, J B Parent, P J Conlon, H G Kasler, C M Tsai, D A Lill-Elghanian, R I Hollingsworth.   

Abstract

Both human bactericidal/permeability-increasing protein (BPI) and a recombinant amino-terminal fragment of BPI (rBPI23) have been shown to bind with high affinity to the lipid A region of lipopolysaccharide (LPS) (H. Gazzano-Santoro, J. B. Parent, L. Grinna, A. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss, and P. J. Conlon, Infect. Immun. 60:4754-4761, 1992). In the present study, lipid A preparations derived from bacterial LPS as well as synthetic lipid A's and various lipid A analogs were used to determine the structural elements required for rBPI23 binding. rBPI23 bound in vitro to a variety of synthetic and natural lipid A preparations (both mono- and diphosphoryl forms), including lipid A's prepared from Escherichia coli and Salmonella, Neisseria, and Rhizobium species. Binding does not require that the origin of negative charge be phosphate, since rBPI23 bound with high affinity to lipid A's isolated from Rhizobium species that contain carboxylate (Rhizobium trifolii) or sulfate (Rhizobium meliloti) anionic groups and lack phosphate. Lipid A acyl chains are important, since rBPI23 did not bind to four synthetic variants of the beta(1-6)-linked D-glucosamine disaccharide lipid A head group, all devoid of acyl chains. rBPI23 also bound weakly to lipid X, a monosaccharide lipid precursor of LPS corresponding to the reducing half of lipid A. Lipid IVA, a precursor identical to E. coli lipid A except that it lacks the 2' and 3' acyl chains, was the simplest structure identified in this study that rBPI23 bound with high affinity. These results demonstrate that rBPI23 has a binding specificity for the lipid A region of LPS and binding involves both electrostatic and hydrophobic components.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768599      PMCID: PMC173286          DOI: 10.1128/iai.63.6.2201-2205.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.

Authors:  M N Marra; C G Wilde; M S Collins; J L Snable; M B Thornton; R W Scott
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

2.  Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity.

Authors:  E T Rietschel; H Brade; L Brade; K Brandenburg; U Schade; U Seydel; U Zähringer; C Galanos; O Lüderitz; O Westphal
Journal:  Prog Clin Biol Res       Date:  1987

3.  The morphologic structure of isolated bacterial lipopolysaccharide.

Authors:  J W Shands; J A Graham; K Nath
Journal:  J Mol Biol       Date:  1967-04-14       Impact factor: 5.469

Review 4.  Endotoxins and disease mechanisms.

Authors:  D C Morrison; J L Ryan
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

5.  Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.

Authors:  B A Mannion; E S Kalatzis; J Weiss; P Elsbach
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

6.  The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.

Authors:  J Weiss; K Muello; M Victor; P Elsbach
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.

Authors:  J Weiss; S Beckerdite-Quagliata; P Elsbach
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

8.  A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis.

Authors:  P S Tobias; J C Mathison; R J Ulevitch
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

9.  A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein.

Authors:  C E Ooi; J Weiss; P Elsbach; B Frangione; B Mannion
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

10.  Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship.

Authors:  P Elsbach; J Weiss; R C Franson; S Beckerdite-Quagliata; A Schneider; L Harris
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

View more
  9 in total

Review 1.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

2.  Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins.

Authors:  D A Eberhard; S R Vandenberg
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.

Authors:  E Elass-Rochard; D Legrand; V Salmon; A Roseanu; M Trif; P S Tobias; J Mazurier; G Spik
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 4.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

5.  Effect of bilayer phospholipid composition and curvature on ligand transfer by the alpha-tocopherol transfer protein.

Authors:  Wen Xiao Zhang; Grant Frahm; Samantha Morley; Danny Manor; Jeffrey Atkinson
Journal:  Lipids       Date:  2009-05-21       Impact factor: 1.880

Review 6.  Antimicrobial-sensing proteins in obesity and type 2 diabetes: the buffering efficiency hypothesis.

Authors:  José María Moreno-Navarrete; José Manuel Fernández-Real
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

7.  Structural and functional features of a developmentally regulated lipopolysaccharide-binding protein.

Authors:  Benjamin C Krasity; Joshua V Troll; Erik M Lehnert; Kathleen T Hackett; Joseph P Dillard; Michael A Apicella; William E Goldman; Jerrold P Weiss; Margaret J McFall-Ngai
Journal:  mBio       Date:  2015-10-13       Impact factor: 7.867

8.  Bactericidal/Permeability-Increasing Protein Is an Enhancer of Bacterial Lipoprotein Recognition.

Authors:  Sigrid Bülow; Lisa Zeller; Maren Werner; Martina Toelge; Jonas Holzinger; Clemens Entzian; Thomas Schubert; Franziska Waldow; Nicolas Gisch; Sven Hammerschmidt; André Gessner
Journal:  Front Immunol       Date:  2018-12-05       Impact factor: 7.561

9.  A Polymorphism of Bactericidal/Permeability-Increasing Protein Affects Its Neutralization Efficiency towards Lipopolysaccharide.

Authors:  Katharina U Ederer; Jonas M Holzinger; Katharina T Maier; Lisa Zeller; Maren Werner; Martina Toelge; André Gessner; Sigrid Bülow
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.